Most tumours do not express HLA class II molecules on their surface but HLA class II restricted CD4+ T cells are nevertheless considered to be mandatory for establishing and maintaining a clinically efficient anticancer immune response (Mumberg et al, 1999; Schurmans et al, 2001). The gene discussed is CD4; the disease is neoplasm.